Table 2.
Prevalence of HPV types in women in Benin with normal and abnormal cytological results
Pap test and HPV performed samples (n = 354) | ||||||
---|---|---|---|---|---|---|
Normal cytology (n = 258) | Abnormal cytology (n = 96) | |||||
HPV type |
Single infection n (%) |
Multiple infection n (%) |
Total n (%) |
Single infection n (%) |
Multiple infection n (%) |
Total n (%) |
HPV + | 45 (17.4) | 24 (9.3) | 69 (26.7) | 28 (29.2) | 22 (22.9) | 50 (52.1) |
High-risk | ||||||
HPV-59 | 11 (24.4) | 11 (45.8) | 22 (31.9) | 7 (25.0) | 5 (22.7) | 12 (24.0) |
HPV-56 | 6 (13.3) | 0 (0.0) | 6 (8.7) | 3 (10.7) | 2 (9.1) | 5 (10.0) |
HPV-16 | 5 (11.1) | 6 (25.0) | 11 (15.9) | 3 (10.7) | 6 (27.3) | 9 (18.0) |
HPV-18 | 4 (8.9) | 4 (16.7) | 8 (11.6) | 3 (10.7) | 5 (22.7) | 8 (16.0) |
HPV-35 | 3 (6.7) | 9 (37.5) | 12 (17.4) | 5 (17.9) | 6 (27.3) | 11 (22.0) |
HPV-58 | 3 (6.7) | 5 (20.8) | 8 (11.6) | 2 (7.1) | 2 (9.1) | 4 (8.0) |
HPV-45 | 3 (6.7) | 1 (4.2) | 4 (5.8) | 0 (0.0) | 8 (36.4) | 8 (16.0) |
HPV-73 | 1 (2.2) | 2 (8.3) | 3 (4.3) | 2 (7.1) | 2 (9.1) | 4 (8.0) |
HPV-39 | 1 (2.2) | 0 (0.0) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
HPV-31 | 1 (2.2) | 1 (4.2) | 2 (2.9) | 0 (0.0) | 3 (13.6) | 3 (6.0) |
HPV-33 | 0 (0.0) | 2 (8.3) | 2 (2.9) | 0 (0.0) | 4 (18.2) | 4 (8.0) |
HPV-51 | 0 (0.0) | 3 (12.5) | 3 (4.3) | 0 (0.0) | 2 (9.1) | 2 (4.0) |
HPV-52 | 0 (0.0) | 1 (4.2) | 1 (1.4) | 2 (7.7) | 1 (4.5) | 3 (6.0) |
Low-risk | ||||||
HPV-42 | 6 (13.3) | 3 (12.5) | 9 (13.0) | 1 (3.6) | 1 (4.5) | 2 (4.0) |
HPV-44 | 1 (2.2) | 0 (0.0) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
HPV-6 | 0 (0.0) | 6 (25.0) | 6 (8.7) | 0 (0.0) | 4 (18.2) | 4 (8.0) |
HPV-11 | 0 (0.0) | 6 (25.0) | 6 (8.7) | 0 (0.0) | 4 (18.2) | 4 (8.0) |
HPV-43 | 0 (0.0) | 2 (8.3) | 2 (2.9) | 0 (0.0) | 3 (13.6) | 3 (6.0) |